Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
819.00    -16.00 (-1.92%)
Bid:
823.00
Ask:
824.00
Spread: 1.00 (0.122%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

22 May 2026 10:09

RNS Number : 4706F
Savills PLC
22 May 2026
Β 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

Buy-out award for incoming Group Chief Financial Officer

The Company announces that on 21 May 2026 it granted the following share awards (the "Awards") to Nick Sanderson to replace awards forfeited by him when he left his previous employer, Great Portland Estates plc ("GPE") to take up his appointment as the Company's Group Chief Financial Officer, which role he assumed on 9 February 2026 (the "Commencement Date"). The Awards were granted under the Savills Deferred Share Bonus Plan.

Level and purpose of Award

As above, the Savills Awards have been granted to replace deferred share bonus plan awards forfeited by Mr Sanderson when he left GPE, and are consistent with Savills Directors' Remuneration Policy and are as disclosed in the Directors' Remuneration Report in the 2025 Savills plc Report & Accounts.

Β 

The foregone deferred share bonus plan awards comprised three nil cost options to acquire GPE ordinary shares, each with a deferral period of three years and a further deferred share bonus plan award to be granted May / June 2026 to reflect personal and measured GPE corporate performance for the 2025/26 financial year.

Β 

The value and number of shares subject to the Awards has been calculated respectively using the share prices of the Company and GPE on the Commencement Date, as adjusted to reflect the Company's share price on the London Stock Exchange Dealing Day preceding the date of grant.

These Awards will vest on the earlier of the originally timetabled vesting date of the forfeited GPE awards or the third anniversary of grant and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased during the Deferred Period to reflect final and interim dividends declared during the deferred period.

Director / PDMR

Number of shares subject to The Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 21 May 2026

Vesting Date

Nick Sanderson (Director)

18,215

2 June 2026

22,240

20 June 2027

23,486

30 May 2028

24,533

21 May 2029

Β 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

Β 

1

Details of the Director / PDMR

a)

Name

Nick Sanderson

2

Reason for the notification

a)

Position/status

Group Chief Financial Officer / Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Β Savills plc

b)

LEI

213800WXICGMBWHTA933

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Savills plc Ordinary shares of 2.5p

GB00B135BJ46

b)

Nature of the transaction

Grant of share awards over ordinary shares pursuant to a bespoke buy-out award arrangement

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

nil consideration

88,474

d)

Aggregated information

- Volume

Β 

- Price

Β 

- Total

Β n/a

Β 

e)

Date of the transaction

21 May 2026

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

Β 

22 May 2026

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGZGZKLZNGVZG
Date   Source Headline
19th Jun 20262:28 pmRNSDirector/PDMR Shareholding
18th Jun 202611:37 amRNSDirector/PDMR Shareholding
11th Jun 20263:20 pmRNSDirector/PDMR Shareholding
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.